Compare ZVRA & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZVRA | AROW |
|---|---|---|
| Founded | 2006 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 499.9M | 442.9M |
| IPO Year | 2015 | N/A |
| Metric | ZVRA | AROW |
|---|---|---|
| Price | $8.10 | $33.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $21.71 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 1.1M | 69.0K |
| Earning Date | 11-05-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | N/A | ★ 5.41 |
| EPS | 0.54 | ★ 2.07 |
| Revenue | $84,388,000.00 | ★ $146,817,000.00 |
| Revenue This Year | $333.25 | $25.16 |
| Revenue Next Year | $43.70 | $9.99 |
| P/E Ratio | ★ $15.11 | $16.02 |
| Revenue Growth | ★ 244.60 | 7.84 |
| 52 Week Low | $6.19 | $22.72 |
| 52 Week High | $13.16 | $33.26 |
| Indicator | ZVRA | AROW |
|---|---|---|
| Relative Strength Index (RSI) | 36.09 | 68.68 |
| Support Level | $8.05 | $30.54 |
| Resistance Level | $8.58 | $32.00 |
| Average True Range (ATR) | 0.34 | 1.12 |
| MACD | -0.00 | 0.19 |
| Stochastic Oscillator | 6.63 | 91.69 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.